Navigation Links
Tiagabine Enhances Sleep Maintenance In Insomnia Patients

Recent research indicates that tiagabine, a selective ?-aminobutyric acid (GABA) reuptake inhibitor, has positive effect on sleep and next-morning alertness and performance in adult patients with primary insomnia.//

Primary insomnia is characterized by difficulty initiating or maintaining sleep and/or nonrestorative sleep, which causes clinically significant distress or impairment in important areas of waking function.

The authors, writing in the journal Sleep Medicine (available online 2 November 2005) assert that since GABA is a major inhibitory neurotransmitter in the central nervous system and tiagabine increases synaptic availability of GABA, hypnotic properties would seem a likely dose-related effect.

The researchers evaluated the effect of tiagabine administered before bedtime at doses from 4 to 16 mg on sleep and next-morning alertness and psychomotor performance in adult patients with primary insomnia.

Fifty-eight middle-aged patients were randomized for the study. Results showed a significant dose-dependent increase in slow wave sleep percentage with all tiagabine doses, a trend toward a dose-dependent increase in total sleep time, and no effect on latency to persistent sleep.

The authors conclude that tiagabine increased slow wave sleep and reduced wake after sleep onset in a dose-dependent manner. Tiagabine dosages up to 8 mg did not compromise next-morning alertness and psychomotor performance in adult patients with primary insomnia. Further investigation of tiagabine doses up to 8 mg is warranted.

The authors suggest that additional studies with tiagabine are warranted to further investigate tiagabine's clinical effects in patients with insomnia. Also of interest are the potential differences associated with increases in slow wave sleep mediated by different neurotransmitter systems.


'"/>




Page: 1

Related medicine news :

1. Animal Fat Enhances Risk Of Stomach
2. Simulated Heart Tissue Enhances Understanding of Arrhythmias And Defibrillator Failure
3. Glivec Enhances Survival Rates In Leukemia
4. Study Claims That Chemo Before And After Surgery Enhances Survival Rates
5. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
6. Haryana Enhances Nutritional Support for Women, Children
7. Loop Incision Treatment Enhances Premature Delivery Risk
8. Sleep apnoea increases post-operative risks
9. Sleep, snoring....stroke
10. Sleeping sickness - a silent killer
11. Deep Sleep Doesnt Increase Memory
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... Prior Lake MN (PRWEB) , ... February 24, ... ... the launch of its newly designed TaskMate Go. Core benefits and advantages built ... grain finish and a stylish, functional look and feel. Ability to gain the ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... An in-depth ... at the University of Pittsburgh points to eight genes that may explain why susceptibility ... according to the results of a study published today in the journal npj Schizophrenia. ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... hearing disabilities, it is so critically important that we all are aware of ... is why Mediaplanet is proud to announce the launch of its newest edition ...
(Date:2/24/2017)... San Diego, CA (PRWEB) , ... February 24, 2017 , ... ... announce its 2017 national conference convening academic faculty engaged in or interested in palliative ... Education and Research,” will be held in North County San Diego on Sept. ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Radiology Business Management Association will ... at the annual Building Better Radiology Marketing Programs conference, held this year ... Worth, Texas. Nine awards are given out in five categories. They are:, ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... SILVER SPRING, Md. , Feb. 23, 2017 ... today allowed marketing of the PhenoTest BC Kit, ... first test to identify organisms that cause bloodstream ... organism is likely to respond to (antibiotic sensitivity). ... it takes to provide this important information, which ...
(Date:2/24/2017)... -- Directors from Pharma To Market Pty Ltd and Ador Consulting Pte ... the founding of Pharma To Market Pte Ltd, based in ... to announce their expansion into Asia with ... The company are delighted to appoint Joelle Chia , former ... based entity. Joelle brings with her an extensive business ...
(Date:2/24/2017)... Medivir AB (Nasdaq Stockholm: MVIR) today announced ... Directors that will be submitted to the 2017 Annual ... the company,s three largest shareholders at the end of ... seat on the Nomination Committee, and the Chairman of ... was as follows:  Anders ...
Breaking Medicine Technology: